Sarah Cannon Research Institute

http://www.sarahcannon.com

Sarah Cannon Research Institute is the research arm of HCA’s global cancer institute, Sarah Cannon. Focused on advancing therapies for patients, it is one of the world’s leading clinical research organizations conducting community-based clinical trials throughout the United States and United Kingdom. Sarah Cannon’s network of strategic sites includes more than 275 physicians who engage in research. The organization has led more than 220 first-in-man clinical trials since its inception in 1993, and has been a clinical trial leader in more than two-thirds of approved cancer therapies over the last 10 years. Additionally, Sarah Cannon offers drug development research support services for industry sponsors as well as strategic investigator’s through its contract research organization (CRO), Sarah Cannon Development Innovations (formerly known as SCRI Development Innovations). As the CRO of Sarah Cannon, it leverages expert physician leadership to design and implement clinical trials that effectively and efficiently lead to rapid clinical development decisions. *

	Start	2016-09-29 existent
	Group	Hospital Corporation of America (HCA) (Group)
	Industry	oncology
	Industry 2	cancer immunotherapy (immuno-oncology, I-O)

	City	n. a. Nashville, TN
		Address record changed: 2016-10-03

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Boehringer Ingelheim. (9/29/16). "Press Release: Boehringer Ingelheim and Sarah Cannon Research Institute Launch Strategic Collaboration to Develop Novel Immune-oncology Therapies". Ingelheim.

		Record changed: 2019-07-13